Target intelligence / Profile preview

Bacterial peptidoglycan (PGN) (PGN)

Target
PGN
Molecular classification
Other, Glycan, Bacterial cell wall component
01

Overview

Bacterial peptidoglycan (PGN), also known as murein, is an essential and unique structural polymer that forms a mesh-like layer outside the cytoplasmic membrane of most bacteria (StatPearls, 2023). It consists of long glycan strands composed of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) residues, which are cross-linked by short peptide chains to provide mechanical strength and maintain cell shape (Nature Reviews Microbiology, 2019). This structure is critical for protecting the bacterium from osmotic lysis due to high internal pressure. Because peptidoglycan is absent in eukaryotic cells, it serves as a highly specific and effective target for antibacterial agents. Glycopeptide antibiotics, such as vancomycin, exert their effect by binding directly to the D-alanyl-D-alanine terminus of the peptidoglycan precursors, thereby inhibiting the assembly and cross-linking of the glycan strands (PubChem, 2024). Additionally, the enzyme lysozyme, a key component of the innate immune system, targets this molecule by hydrolyzing the beta-1,4-glycosidic bonds between NAM and NAG, leading to cell wall degradation and bacterial death (Microbiology and Molecular Biology Reviews, 2006).

Other names
MureinNAM-NAG polymerPeptidoglycan backboneCell wall glycanPeptidoglycan-linked NAM-NAG glycan strands
02

Mechanism of action

Inhibition of cell wall synthesis by binding to the D-alanyl-D-alanine terminus of peptidoglycan precursors, preventing polymerization and cross-linking of glycan strands (PubChem, 2024). Enzymatic hydrolysis of the beta-1,4-glycosidic bonds between N-acetylmuramic acid and N-acetylglucosamine residues in the glycan backbone (Microbiology and Molecular Biology Reviews, 2006).

03

Biological functions

Immune responseOther
04

Disease associations

InfectionInflammation
05

Safety considerations

Development of antimicrobial resistance (e.g., Vancomycin-resistant Enterococci)NephrotoxicityOtotoxicityInfusion-related reactions (e.g., Red man syndrome)Hypersensitivity reactions
06

Interacting drugs

Vancomycin

5 more in the full profile.

07

Biomarkers

Peptidoglycan recognition proteins (PGRPs)Soluble CD14ProcalcitoninC-reactive protein (CRP)

Beyond the preview

Go deeper on Bacterial peptidoglycan (PGN) (PGN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial peptidoglycan (PGN) (PGN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call